암 치료용 나노기술 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법·규제 환경, 신기술 및 기술개발 동향, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 개요
- 특허 분석
- Porter's Five Forces 분석
- 향후 전망
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- 세계적인 암 이환율 증가
- 정부 자금과 의약품 연구개발비 증가
- 암 치료의 나노입자 : 이점
- 나노재료에 의한 암 세포 정밀 표적화
- 시장 성장 억제요인
- 나노입자 임상 사용의 장애
- 종양 전문가의 부족
- 시장 기회
- 약제 내성 극복의 나노입자 메커니즘
- 암 단백질체학
제4장 규제 상황
제5장 신기술과 신개발
- 최신 동향과 기술
- AI
- 양자점
- 종양 제품 파이프라인
제6장 시장 부문 분석
- 세분화 내역
- 시장 분석 : 제품 유형별
- 세계의 시장 규모 및 예측
- 리포솜
- 폴리머 나노입자
- 미셀
- 하이드로겔
- 덴드리머
- 시장 분석 : 암 유형별
- 세계의 시장 규모 및 예측
- 폐암
- 유방암
- 백혈병
- 림프종
- 흑색종
- 기타
- 지역적 내역
- 시장 분석 : 지역별
- 세계의 시장 규모 및 예측
- 북미
- 유럽
- 아시아태평양
- 중동 및 아프리카
- 남미
제7장 경쟁 정보
제8장 부록
- 조사 방법
- 약어
- 정보 출처
- 기업 개요
- ASTRAZENECA
- BAXTER
- BOSTON SCIENTIFIC CORP.
- BRISTOL-MYERS SQUIBB CO.
- F. HOFFMANN-LA ROCHE LTD.
- JAZZ PHARMACEUTICALS INC.
- LES LABORATOIRES SERVIER
- NOVARTIS AG
- PFIZER INC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- 기타 신흥 기업
ksm
The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.
Report Scope
This report provides detailed information about nanotechnology in the cancer treatment market. The report analyzes the market trends for nanotechnology in cancer treatment with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report highlights nanotechnology in cancer treatment's current and future market potential and analyzes the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities. The report also covers market estimates for 2029 and market shares for key players.
The market scope in this report is segmented into product type and cancer types. Based on product type, the market is segmented into liposomes, polymeric nanoparticles, micelles, hydrogels, and dendrimers. The market is segmented by cancer type into lungs, breast, leukemia, lymphoma, melanoma and other cancers.
The market has been segmented into the following regions: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment includes a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. For market projections, data will be provided for 2023 as the base year, with forecasts for 2024 through 2029.
The report's goals include:
- Analyzing product and cancer type.
- Analyzing global market size and segments.
- Reviewing market constraints and drivers.
- Providing detailed market forecasts for 2029.
- Assessing market shares, competitiveness and industry structure.
- Identifying potential long-term impacts on nanotechnology in the cancer treatment market.
Report Includes
- Analyses of the trends in global markets for nanotechnology in cancer treatment, with revenue data for 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
- Estimates of the size and revenue prospects for the global market, along with a market share analysis by product type, application and region
- Facts and figures pertaining to the global market dynamics, technological advances, regulations and standards, and the impact of macroeconomic factors
- Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
- Information pertaining to evolving trends and patterns, recent technological breakthroughs, and the types of nanostructured materials, nanodevices, and nanotools used for research, diagnosis and therapy of the types of cancer
- Statistics regarding the incidence and prevalence of cancer cases, as well as global mortality figures
- Analysis of relevant patents and patent grants
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of leading companies
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Patent Analysis
- Analysis of Porter's Five Forces
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
- Future Perspective
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Prevalence of Cancer Cases Globally
- Rise in Government Funding and Pharmaceutical R&D Spending
- Nanoparticles in Cancer Treatment: Advantages
- Precision Targeting of Cancer Cells with Nanomaterials
- Market Restraints
- Roadblocks to Clinical Nanoparticle Use
- Lack of Oncology Professionals
- Market Opportunities
- Mechanism of Nanoparticles in Overcoming Drug Resistance
- Cancer Proteomics
Chapter 4 Regulatory Landscape
- Overview
- U.S.
- Europe
- Japan
Chapter 5 Emerging Technologies and New Developments
- Emerging Trends and Technologies
- Artificial Intelligence
- Quantum Dots
- Oncology Products Pipeline
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Global Market Size and Forecast
- Liposomes
- Polymeric Nanoparticles
- Micelles
- Hydrogels
- Dendrimers
- Market Analysis by Cancer Type
- Global Market Size and Forecast
- Lung Cancer
- Breast Cancer
- Leukemia
- Lymphoma
- Melanoma
- Other Cancers
- Geographic Breakdown
- Market Analysis by Region
- Global Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Chapter 7 Competitive Intelligence
- Overview
- Competitive Landscape
Chapter 8 Appendix
- Methodology
- Abbreviations
- Sources
- Company Profiles
- ASTRAZENECA
- BAXTER
- BOSTON SCIENTIFIC CORP.
- BRISTOL-MYERS SQUIBB CO.
- F. HOFFMANN-LA ROCHE LTD.
- JAZZ PHARMACEUTICALS INC.
- LES LABORATOIRES SERVIER
- NOVARTIS AG
- PFIZER INC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Other Emerging Players
